Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2009

01-04-2009 | Gastrointestinal Oncology

APC, MYH, and the Correlation Genotype-Phenotype in Colorectal Polyposis

Authors: Jérémie H. Lefevre, MD, Yann Parc, MD, PhD, Magali Svrcek, MD, Solen Kernéis, MD, Chrystelle Colas, MD, Conor Shields, MD, Jean-François Flejou, MD, Rolland Parc, MD, FACS, Emmanuel Tiret, MD

Published in: Annals of Surgical Oncology | Issue 4/2009

Login to get access

Abstract

Background

Familial adenomatous polyposis (FAP) has been divided into two entities: classical (CFAP) and attenuated (AFAP). With the discovery of MYH associated polyposis (MAP) syndrome, the clinical differences have become unclear. The aim of our study was to investigate patients with polyposis treated in our institution for a correlation between genotype and phenotype.

Methods

Between 1978 and 2007, 515 patients were followed. Four groups were identified: AFAP, CFAP, MAP, and no-mutation patients. Clinical, surgical, histological, and genetic data of patients were collected and compared. Two ranges of mutations responsible for AFAP were used.

Results

Patient breakdown was CFAP patients (n = 322/294), AFAP patients (n = 13/41), MYH patients (n = 17) and no-mut patients (n = 32). Patients not tested for APC mutation (n = 131) were excluded. Genotype/phenotype evaluation showed no difference in the number or location of polyps, age at colectomy, presence of cancer, or duodenal polyps. Major differences were found for MYH patients: later age at diagnosis, more cancers, fewer polyps, and more located in the right part of the colon. For phenotype/genotype correlation, patients aged more than 35 years at the time of colectomy and with fewer than 100 polyps had significantly more mutation found on MYH.

Conclusions

This two-way analysis did not show any correlation that might help to identify a subgroup of patients with APC mutation that may be considered attenuated. It is more likely that the MAP syndrome is the real AFAP.
Literature
1.
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004;28:877–81.PubMedCrossRef
2.
3.
Grady WM. Genetic testing for high-risk colon cancer patient. Gastroenterology. 2003;124:1574–94.PubMedCrossRef
4.
Benamouzig R, Chaussade S, Olschwang S. Polyposis coli: a practical approach. Gastroenterol Clin Biol. 2005;29:1035–9.PubMedCrossRef
5.
Penna CP, Tiret E, Kartheuser AH, Olschwang S, Parc R. Value of screening of familial adenomatous polyposis for prevention of colorectal cancer. Gastroenterol Clin Biol. 1992;16:210–4.PubMed
6.
Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer. 1995;76:2427–33.PubMedCrossRef
7.
Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in APC and phenotype of familial adenomatous polyposes (FAP): A review of the literature. Crit Rev Oncol/Hematol. 2007;61:153–61.CrossRef
8.
Scott RJ, Meldrum C, Crooks R, Spigelman AD, Kirk J, Tucker K, et al. Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut. 2001;48:508–14.PubMedCrossRef
9.
Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer. 2003;2:43–55.PubMedCrossRef
10.
Beroud C, Soussi T. APC gene: database of germline and somatic mutation in human tumors and cell lines. Nucl Acids Res. 1996;24:121–4.PubMedCrossRef
11.
Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993;75:951–7.PubMedCrossRef
12.
Gebert JF, Dupon C, Kadmon M, Hahn M, Herfarth C, von Knebel Doeberitz M, et al. Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. Ann Surg. 1999;229:350–61.PubMedCrossRef
13.
Van der Luitj RB, Vassen HF, Tops CM, Breukel C, Fodde R, Meera Khan P. APC mutation in the alternatively spliced region of exon 9 associated with late onset of adenomatous polyposis. Hum Genet. 1995;96:705–10.CrossRef
14.
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology. 2004;127:444–51.PubMedCrossRef
15.
16.
Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut. 2002;50:845–50.PubMedCrossRef
17.
Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposes. Lancet. 1996;348:433–5.PubMedCrossRef
18.
Wu JS, Paul P, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg. 1998;227:57–62.PubMedCrossRef
19.
Bülow C, Vasen H, Järvinen H, Björk J, Bisgaard ML, Bülow S. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposes. Gastroenterology. 2000;119:1454–60.PubMedCrossRef
20.
Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposes? Experience from 680 FAP families. Gut. 2001;48:515–21.PubMedCrossRef
21.
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–32.PubMedCrossRef
22.
Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, et al. Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYH. N Engl J Med. 2003;348:791–9.PubMedCrossRef
23.
Lefevre JH, Rodrigue CM, Mourra N, Bennis M, Flejou JF, Parc R, et al. Implication of MYH in colorectal polyposis. Ann Surg. 2006;244:874–80.PubMedCrossRef
24.
Bussey HJR. Familial Polyposis Coli. Baltimore: John Hopkins Univeristy Press 1975.
25.
Johns LE, Houslton RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2292–3003.CrossRef
26.
Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet. 1995;4:337–40.PubMedCrossRef
27.
Houlston R, Crabtree M, Phillips R, Crabtree M, Tomlinson I. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut. 2001;48:1–5.PubMedCrossRef
28.
Matsuo S, Eguchi S, Azuma T, Hidaka M, Yamaguchi S, Hayashi T, et al. Attenuated familial adenomatous polyposis associated with advanced rectal cancer in a 16-year-old boy: report of a case. Surg Today. 2001;31:1020–3.PubMedCrossRef
29.
Giardiello FM, Krush AJ, Petersen GM, Booker SV, Kerr M, Tong LL, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology. 1994;106:1542–7.PubMed
30.
Sieber OM, Segditsas S, Knudsen AL, Zhang J, Luz J, Rowan AJ, et al. Disease severity and genetic pathways in attenuated familial polyposis vary greatly but depend on the site of the germline mutation. Gut. 2006;55:1440–8.PubMedCrossRef
31.
Lamlum H, Al Tassan N, Jaeger E, Frayling I, Sieber O, Reza FB, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet. 2000;9:2215–21.PubMed
32.
Sieber OM, Lamlum H, Crabtree MD, Rowan AJ, Barclay E, Lipton L, et al. Whole gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or multiple colorectal adenomas. Proc Natl Acad Sci USA. 2000;99:2954–8.CrossRef
33.
Nilbert M, Fernebro J, Kristofferson U. Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome. Scand J Gastroenterol. 2000;35:1200–3.PubMedCrossRef
Metadata
Title
APC, MYH, and the Correlation Genotype-Phenotype in Colorectal Polyposis
Authors
Jérémie H. Lefevre, MD
Yann Parc, MD, PhD
Magali Svrcek, MD
Solen Kernéis, MD
Chrystelle Colas, MD
Conor Shields, MD
Jean-François Flejou, MD
Rolland Parc, MD, FACS
Emmanuel Tiret, MD
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0297-0

Other articles of this Issue 4/2009

Annals of Surgical Oncology 4/2009 Go to the issue

Breast Oncology

A Contemporary, Population-Based Study of Lymphedema Risk Factors in Older Women with Breast Cancer

ORIGINAL ARTICLE-THORACIC ONCOLOGY

Surgical Factors Influence the Outcome After Ivor-Lewis Esophagectomy with Intrathoracic Anastomosis for Adenocarcinoma of the Esophagogastric Junction: A Consecutive Series of 240 Patients at an Experienced Center

Breast Oncology

Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?

Thoracic Oncology

Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience

Gastrointestinal Oncology

Laparoscopic Peritoneal Cytology: Can it Affect Decision-Making for Neoadjuvant Treatment of Gastric Cancer?

Erratum

Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer